Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kashiv BioSciences is a fully integrated biopharmaceutical company specializing in the development and manufacturing of high-quality biosimilars and innovative biologics. The company maintains a diverse pipeline targeting complex therapeutic areas such as oncology, immunology, and endocrinology. Kashiv leverages its advanced R&D capabilities and state-of-the-art manufacturing facilities to provide affordable alternatives to expensive reference biologics. With several products already commercialized through strategic partnerships, the company is positioned as a significant player in the global biosimilar market. Headquartered in New Jersey, Kashiv operates with a focus on end-to-end drug development, from cell line engineering to commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KASHX Bio.